Macroalgae Consumption - a Pilot Study
1 other identifier
interventional
49
1 country
1
Brief Summary
In this study, the aim is to investigate the food safety of macroalgae. There will be an analysis of macroalgae products for the concentration of cadmium, inorganic arsenic, and iodine in macroalgae, as well as measure the status of these elements in consumers. An investigation of the thyroid function of macroalgae consumers and the use of metabolomics to explore which biological changes occur when consuming seaweed and kelp and when the consumer excludes macroalgae from their diet will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 6, 2023
CompletedFirst Posted
Study publicly available on registry
July 11, 2023
CompletedJuly 11, 2023
July 1, 2023
12 months
March 6, 2023
July 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Consumption of macroalgae products
Assess the dietary consumption of macroalgae in consumers in the Bergen and Oslo area by 24hr recall and food frequency questionnaire
Through study completion, on average 6 weeks
Levels of iodine, cadmium and inorganic arsenic in macroalgae products
Analyse the levels of iodine, cadmium and inorganic arsenic in macroalgae products used by the participants
Through study completion, on average 6 weeks
Secondary Outcomes (11)
Levels of iodine
6 weeks
Levels of cadmium in urine
6 weeks
Levels of inorganic arsenic in urine
6 weeks
Levels of creatinine in urine
6 weeks
Thyroid function measure by thyroid-stimulating hormon
6 weeks
- +6 more secondary outcomes
Study Arms (2)
Usual macroalgae consumption
ACTIVE COMPARATORCrossover design with habitual macroalgae consumption at baseline
Cessation of macroalgae consumption
EXPERIMENTALCessation of macroalgae consumption as an experimental intervention.
Interventions
The participant have a habitual macroalgae consumption at baseline.
The participants exclude any macroalgae products from their diet
Eligibility Criteria
You may qualify if:
- adults
- weekly consumer of macroalgae
You may not qualify if:
- pregnant
- known disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bergenlead
- Institute of Marine Researchcollaborator
Study Sites (1)
University of Bergen
Bergen, 5021, Norway
Study Officials
- PRINCIPAL INVESTIGATOR
Inger Aakre, PhD
Institute of Marine Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2023
First Posted
July 11, 2023
Study Start
January 1, 2022
Primary Completion
December 15, 2022
Study Completion
January 1, 2023
Last Updated
July 11, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share